Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer
- Status
- TERMINATED
- Phase
- NA
Clinical Trials Related to Cetuximab
Related studies linked through entity extraction aliases.
S1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Efficacy and Safety of LJM716 and Cetuximab in Head and Neck Squamous Cell Carcinoma Patients
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
- Status
- RECRUITING
- Phase
- PHASE2
A Phase Ib Study of Neoadjuvant of Cetuximab Plus Motolimod and Cetuximab Plus Motolimod Plus Nivolumab
- Status
- TERMINATED
- Phase
- PHASE1
Weekly Carboplatin, Paclitaxel and Cetuximab Treatment for Patients With Recurrent or Metastatic SCCHN
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Changes in Tumor Tissue and Serum Biomarkers Before and After Cetuximab Combined With Preoperative Radiotherapy in Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Combination Study of Urelumab and Cetuximab in Patients With Advanced/Metastatic Colorectal Cancer or Advanced/Metastatic Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141)
- Status
- COMPLETED
- Phase
- PHASE3
PD 0332991 and Cetuximab in Patients With Incurable SCCHN
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Regorafenib and Cetuximab in Patients With Advanced Malignancy
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Tolerance of Maintenance Therapy in Patients With Incurable Advanced Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
SBRT With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated SCCHN
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Combination of Cetuximab and Methotrexate in Recurrent or Metastatic Cancer of the Head and Neck
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
CetuGEX™ in Comparison to Cetuximab for the Treatment of Patients With Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and Neck
- Status
- TERMINATED
- Phase
- PHASE4
Efficacy and Safety of Cetuximab in Metastatic Penile Carcinoma (PENILANE)
- Status
- WITHDRAWN
- Phase
- PHASE2
Post-operative Radiation With Cetuximab for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Cisplatin Plus Radiotherapy Compared to Cetuximab Plus Radiotherapy in Locally Advanced Head and Neck Cancer.
- Status
- COMPLETED
- Phase
- PHASE3